pubmed · eo1.org

[Gestagen therapy in bladderneck adenoma. III. Clinicochemical findings and course controls in patients with bladderneck adenomas under gestagen therapy].

PMID 200033 · Zeitschrift fur Urologie und Nephrologie · 1977

Authors: G Unger; W Baumann; G Horn

Abstract

It is reported on clinico-chemical examinations in 30 carriers of adenomas, who underwent a gestagen therapy lasting 3 months. The treatment was performed in group I in 15 patients with progesterone depot and in group II with depostate. After the end of the treatment in group I an increase of the content of the sodium ions was found. The infections of the urinary tract improved. Neither in negative sense nor in positive sense an influence of the therapy on the other examination parameters was found.

Adenoma; Aged; Blood Urea Nitrogen; Creatinine; Humans; Hydroxyprogesterones; Leukocytes; Middle Aged; Phosphoric Monoester Hydrolases; Proteinuria; Uric Acid; Urinary Bladder Neoplasms

PubMed record

Cite

G Unger; W Baumann; G Horn. [Gestagen therapy in bladderneck adenoma. III. Clinicochemical findings and course controls in patients with bladderneck adenomas under gestagen therapy]. Zeitschrift fur Urologie und Nephrologie (1977). PMID 200033.